A major patient monitoring partnership and improving financial outlook are drawing fresh attention to Philips, as analysts see potential for further long-term growth
Amsterdam, Netherlands, 6 July 2026...
TRUQAP becomes the first targeted treatment approved for patients with PTEN-deficient metastatic hormone-sensitive prostate cancer, marking a major step forward in precision medicine
Wilmington, Delaware, 15 June 2026...
The medical technology company launches a pilot study for a portable 12-lead ECG patch designed to help detect heart problems outside hospitals and clinics.
Austin, Texas, 18 May...
Authorities launch emergency response and passenger surveillance amid growing concerns over potential hantavirus exposure
Washington, D.C., 11 May 2026 – Health authorities across the United States have expanded...